Dr. Reddy's Laboratories
149 hedge funds and large institutions have $1.11B invested in Dr. Reddy's Laboratories in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 50 increasing their positions, 58 reducing their positions, and 20 closing their positions.
4.3% less ownership
Funds ownership: 55.29% → 50.99% (-4.3%)
7% less funds holding
Funds holding: 161 → 149 (-12)
14% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 58
18% less capital invested
Capital invested by funds: $1.35B → $1.11B (-$246M)
51% less call options, than puts
Call options by funds: $2.19M | Put options by funds: $4.45M
55% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$11.2M |
| 2 |
Millennium Management
New York
|
+$10.3M |
| 3 |
JP Morgan Chase
New York
|
+$9.12M |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.77M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
-$36.9M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$27.2M |
| 3 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$15.6M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$7.03M |
| 5 |
CCM
Causeway Capital Management
Los Angeles,
California
|
-$5.44M |
RDY Hedge Fund Activity: Q3 2021 in Review
149 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2021, worth a combined $1.11B — down 18% from $1.35B a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of RDY and 9 opened new positions — a net loss of 11 holders — while 58 trimmed existing stakes and 50 added.
The largest buyer was Goldman Sachs, adding an estimated $11.2M. The largest seller was Schroder Investment Management Group, cutting an estimated $36.9M.
- 149 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2021, down from 161 in Q2 2021.
- Funds reported $1.11B of Dr. Reddy's Laboratories stock for Q3 2021, down 18% quarter-over-quarter.
- 9 funds opened new Dr. Reddy's Laboratories positions in Q3 2021 and 20 closed out, a net change of -11 holders.
- The largest Dr. Reddy's Laboratories buyer in Q3 2021 was Goldman Sachs, an estimated $11.2M added.
- The largest Dr. Reddy's Laboratories seller in Q3 2021 was Schroder Investment Management Group, an estimated $36.9M sold.
Based on aggregated 13F filings for Q3 2021.